About Cardiologs
Cardiologs focuses on improving the diagnosis and management of cardiovascular diseases using artificial intelligence. The company offers a platform that automates the analysis of electrocardiograms (ECGs), allowing healthcare professionals to quickly and accurately identify over 20 types of arrhythmia events. This platform is clinically validated, which means it has been tested and proven to enhance the accuracy of diagnoses. Unlike many competitors, Cardiologs provides a subscription-based service that ensures continuous access to its tools for healthcare institutions and professionals. The main goal of Cardiologs is to streamline workflows for clinicians and enhance patient care on a global scale.
Paris, FranceHeadquarters
2014Year Founded
$22.4MTotal Funding
SERIES_ACompany Stage
AI & Machine Learning, HealthcareIndustries
51-200Employees
Benefits
Annual offsite - Each year we take the team to a different destination for 3-4 days.
Mobility package - Public transportation and cycling benefits.
Flexible WFO/ WFH policy - An agile work environment is super important to us.
Breakfast & Co - We provide daily tea and coffee, cereals and organic fruits.
Weekly Yoga class - Find balance & flexibility with Yoga at the office.
Referral program - We grant a bonus for a recruit from within your network.
F&B Vouchers - Subsidize 50% of restaurant tickets every month.
Monthly drinks - Team get together over drinks and snacks.
Risks
Emerging AI startups in cardiac diagnostics threaten Cardiologs' market share.
Data privacy concerns may arise with stricter patient data regulations.
Frequent platform updates due to rapid tech advancements could raise operational costs.
Differentiation
Cardiologs uses AI to transform cardiac diagnostics with high clinical accuracy.
The platform detects over 20 arrhythmia events, enhancing diagnostic specificity and sensitivity.
Cardiologs' deep learning tech was the first to receive regulatory clearance in its field.
Upsides
Wearable ECG devices' popularity boosts Cardiologs' remote monitoring integration opportunities.
Global digital health market growth increases demand for Cardiologs' AI diagnostic tools.
FDA's AI device approvals may expedite Cardiologs' future innovation clearances.
Funding
Total raised$22.40 M
Latest valuation$75.00 M
StageSERIES_A
SERIES A
12/31/2019$15
$75.00 MSEED
11/30/2015$1
$5.00 MANGEL
4/30/2015N/A
$600.0 K